Tirzepatide (the active ingredient in Mounjaro) has been found to affect how your body absorbs the contraceptive pill
A promising future GLP-1 receptor agonists offer a promising future for the treatment of patients with obesity
Newsome, P
Glucagon-like peptide 1 (GLP-1) receptor agonists use during pregnancy: safety data from regulatory clinical trials
A diabetic, Charles was now unable to afford his medication
GLP-1 side effects should be discussed with a doctor when nausea, constipation, vomiting, reflux, fatigue, dizziness, abdominal pain, dehydration, or poor intake interferes with daily life, prevents the patient from eating enough protein or drinking enough fluid, worsens after a dose increase, persists for more than a short adjustment period, or feels severe or unusual